n-cyclopropyl adenosine-5'-carboxamide has been researched along with cilostamide in 1 studies
Studies (n-cyclopropyl adenosine-5'-carboxamide) | Trials (n-cyclopropyl adenosine-5'-carboxamide) | Recent Studies (post-2010) (n-cyclopropyl adenosine-5'-carboxamide) | Studies (cilostamide) | Trials (cilostamide) | Recent Studies (post-2010) (cilostamide) |
---|---|---|---|---|---|
14 | 0 | 5 | 192 | 0 | 67 |
Protein | Taxonomy | n-cyclopropyl adenosine-5'-carboxamide (IC50) | cilostamide (IC50) |
---|---|---|---|
cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.005 | |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | 0.005 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 3.5775 | |
Platelet-activating factor receptor | Homo sapiens (human) | 3.687 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.005 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.0502 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.0362 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
1 other study(ies) available for n-cyclopropyl adenosine-5'-carboxamide and cilostamide
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |